T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (678)	3/9/1999 11:23:00 AM
From: Andrew G.	Read Replies (1) of 1073

Richard: Big news from Techniclone this morning. What is your take on it? I noticed on message saying: "The interest by Schering in VTA also implies they examined the preclinical data and overall approach to this form of therapy which is still limited to preclinical studies. Their interest somewhat validates this product of the pipeline... " TCLN is still well below their 52 wk high trading presently at about 1 3/8 + 5/32 on heavy volume. Techniclone Completes Licensing Agreement for Oncolym With Schering AG, Germany Under the terms of the Agreement, Schering AG will pay Techniclone up to $20 million cash in the form of milestone payments/capital costs for commercial radiolabeling scaleup, including a $3 million cash up-front fee paid to Techniclone at the execution of the Agreement. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next